JPWO2020152132A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020152132A5
JPWO2020152132A5 JP2021542335A JP2021542335A JPWO2020152132A5 JP WO2020152132 A5 JPWO2020152132 A5 JP WO2020152132A5 JP 2021542335 A JP2021542335 A JP 2021542335A JP 2021542335 A JP2021542335 A JP 2021542335A JP WO2020152132 A5 JPWO2020152132 A5 JP WO2020152132A5
Authority
JP
Japan
Prior art keywords
atoms
nch
trisubstituted
unsubstituted
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021542335A
Other languages
English (en)
Japanese (ja)
Other versions
JP7600119B2 (ja
JP2022524914A5 (https=
JP2022524914A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/051347 external-priority patent/WO2020152132A1/en
Publication of JP2022524914A publication Critical patent/JP2022524914A/ja
Publication of JP2022524914A5 publication Critical patent/JP2022524914A5/ja
Publication of JPWO2020152132A5 publication Critical patent/JPWO2020152132A5/ja
Application granted granted Critical
Publication of JP7600119B2 publication Critical patent/JP7600119B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021542335A 2019-01-22 2020-01-21 アデノシン受容体アンタゴニストとしてのチアゾロピリジン誘導体 Active JP7600119B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19152961 2019-01-22
EP19152961.9 2019-01-22
PCT/EP2020/051347 WO2020152132A1 (en) 2019-01-22 2020-01-21 Thiazolopyridine derivatives as adenosine receptor antagonists

Publications (4)

Publication Number Publication Date
JP2022524914A JP2022524914A (ja) 2022-05-11
JP2022524914A5 JP2022524914A5 (https=) 2023-01-31
JPWO2020152132A5 true JPWO2020152132A5 (https=) 2023-01-31
JP7600119B2 JP7600119B2 (ja) 2024-12-16

Family

ID=65199346

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021542335A Active JP7600119B2 (ja) 2019-01-22 2020-01-21 アデノシン受容体アンタゴニストとしてのチアゾロピリジン誘導体

Country Status (23)

Country Link
US (1) US12344623B2 (https=)
EP (1) EP3914600B1 (https=)
JP (1) JP7600119B2 (https=)
KR (1) KR102891741B1 (https=)
CN (1) CN113939520B (https=)
AR (1) AR117844A1 (https=)
AU (1) AU2020211697B2 (https=)
BR (1) BR112021014406A2 (https=)
CA (1) CA3127284A1 (https=)
DK (1) DK3914600T3 (https=)
ES (1) ES2992081T3 (https=)
FI (1) FI3914600T3 (https=)
HR (1) HRP20241385T1 (https=)
HU (1) HUE068968T2 (https=)
IL (1) IL285024A (https=)
LT (1) LT3914600T (https=)
MX (1) MX2021008510A (https=)
PL (1) PL3914600T3 (https=)
PT (1) PT3914600T (https=)
RS (1) RS66038B1 (https=)
SG (1) SG11202107858WA (https=)
SI (1) SI3914600T1 (https=)
WO (1) WO2020152132A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022258622A1 (en) 2021-06-07 2022-12-15 Ares Trading S.A. Combination treatment of cancer
CN119173276A (zh) 2022-04-13 2024-12-20 吉利德科学公司 用于治疗表达Trop-2的癌症的组合疗法
KR20250048043A (ko) 2022-08-02 2025-04-07 메르크 파텐트 게엠베하 (S)-7-옥사-2-아자-스피로[4.5]데칸-2-카르복실산 [7-(3,6-디히드로-2H-피란-4-일)-4-메톡시-티아졸로[4,5-c]피리딘-2-일]-아미드의 신규의 결정질 형태 및 이의 공-결정 형태
CN116217511B (zh) * 2023-03-22 2024-04-19 沈阳药科大学 一种双靶点化合物及其制备方法和在制备sEH抑制剂与PPARs激动剂中的应用
WO2025137640A1 (en) 2023-12-22 2025-06-26 Gilead Sciences, Inc. Azaspiro wrn inhibitors

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125828A (en) 1972-08-04 1978-11-14 Med-El Inc. Method and apparatus for automated classification and analysis of cells
US4207554A (en) 1972-08-04 1980-06-10 Med-El Inc. Method and apparatus for automated classification and analysis of cells
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
BR9707495A (pt) 1996-02-13 1999-07-27 Zeneca Ltd Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente
US6291455B1 (en) 1996-03-05 2001-09-18 Zeneca Limited 4-anilinoquinazoline derivatives
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
AU1688599A (en) 1998-01-05 1999-07-26 Eisai Co. Ltd. Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
US6841549B1 (en) 1999-07-02 2005-01-11 Eisai Co., Ltd. Condensed imidazole compounds and a therapeutic agent for diabetes mellitus
NZ522074A (en) 2000-05-31 2004-06-25 Astrazeneca Ab Indole derivatives with vascular damaging activity
AU8181701A (en) * 2000-06-21 2002-01-02 Hoffmann La Roche Benzothiazole derivatives
IL153484A0 (en) 2000-07-07 2003-07-06 Angiogene Pharm Ltd Colchinol derivatives as angiogenesis inhibitors
CN1255392C (zh) 2000-07-07 2006-05-10 安吉奥金尼药品有限公司 作为血管生成抑制剂的秋水仙醇衍生物
WO2004089942A2 (en) 2001-10-02 2004-10-21 Acadia Pharmaceuticals Inc. Benzimidazolidinone derivatives as muscarinic agents
US6734179B2 (en) * 2001-12-12 2004-05-11 Hoffmann-La Roche Inc. Benzothiazoles
EP1465634B1 (en) 2001-12-12 2014-10-22 The Government of the United States of America, as represented by the Secretary Department of Health and Human Services Methods for using adenosine receptor inhibitors to enhance immune response and inflammation
EP1618108A2 (en) 2003-04-09 2006-01-25 Biogen Idec MA Inc. Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosine receptor antagonists
JP4444290B2 (ja) 2003-05-19 2010-03-31 エフ.ホフマン−ラ ロシュ アーゲー アデノシン受容体リガンドとしてのベンゾチアゾール誘導体
BRPI0414266A (pt) * 2003-09-19 2006-11-07 Hoffmann La Roche derivados de tiazolopiridina como ligandos receptores da adenosina
US7054288B2 (en) * 2004-02-13 2006-05-30 Interdigital Technology Corporation Method and apparatus for providing fast detection of a high speed shared control channel
DE102004008908A1 (de) * 2004-02-24 2005-09-08 Patent-Treuhand-Gesellschaft für elektrische Glühlampen mbH Ansteuerschaltung für Wandler
FR2867354A1 (fr) * 2004-03-09 2005-09-16 Joseph Vaillant Ferrure mecanique pour sabot, notamment pour cheval de sport
CN1989139B (zh) 2004-07-22 2010-05-12 弗·哈夫曼-拉罗切有限公司 苯并噻唑衍生物
WO2014101120A1 (en) 2012-12-28 2014-07-03 Merck Sharp & Dohme Corp. Heterobicyclo-substituted-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
US11220492B2 (en) * 2017-05-17 2022-01-11 Arcus Biosciences, Inc. Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders
RS64035B1 (sr) * 2017-08-01 2023-04-28 Merck Patent Gmbh Derivati tiazolopiridina kao antagonisti receptora adenozina

Similar Documents

Publication Publication Date Title
RU2373209C2 (ru) Пирролотриазиновые соединения как ингибиторы киназ
JP2021535177A5 (https=)
AR037972A1 (es) Pirrolopirimidinas
RU2009115653A (ru) Производные 5-замещенного хиназолинона, содержащие их композиции и способы их применения
JPWO2020243415A5 (https=)
JP2004534774A5 (https=)
JP2012508252A5 (https=)
RU2007148217A (ru) Получение производных n-фенил-2-пиримидинамина
JP2021535174A5 (https=)
JP2009502845A5 (https=)
JP2021535159A5 (https=)
JPWO2020152132A5 (https=)
CA2506242A1 (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
RU2007136535A (ru) Пептидомиметические соединения и получение биологически активных производных
JP2020528922A5 (https=)
JPWO2019038215A5 (https=)
JPWO2019038214A5 (https=)
JP2020502116A5 (https=)
JP2006513222A5 (https=)
RU2008149936A (ru) (2r)-2-[(4-сульфонил)аминофенил]пропанамиды и содержащие их фармацевтические композиции
RU2007135355A (ru) Производные изохинолина и способы их применения
JP2002501043A5 (https=)
RU2006134024A (ru) Тетрациклические производные лактама и их использование
JPWO2019025099A5 (https=)
RU2008131907A (ru) Новые соединения